Literature DB >> 15854631

Medical abortion at 9-13 weeks' gestation: a review of 1076 consecutive cases.

Haitham Hamoda1, Premila W Ashok, Gillian M M Flett, Allan Templeton.   

Abstract

OBJECTIVE: The aim of the study was to assess the use, efficacy and factors influencing the outcome of medical abortion at 9-13 weeks' gestation.
METHODS: Retrospective chart review of consecutive women undergoing medical abortion at 9-13 weeks' gestation was done.
RESULTS: A total of 1927 abortions were carried out at 9-13 weeks' gestation, of which 1076 (55.8%) were undertaken medically. Efficacy decreased with increasing gestation (p=.02). Surgical evacuation was carried out in 45 (4.2%) women including 10 (2.7%) at 64-70 days, 11 (3.3%) at 71-77 days, 10 (5.1%) at 78-84 days and 14 (8.0%) at 85-91 days of gestation (p=.02). Indications for surgery included continuing pregnancy [16 (1.5%) women], retained sac [5 (0.5%)], incomplete abortion [20 (1.9%)] and emergency curettage for bleeding [4 (0.4%)]. The number of misoprostol doses used and the induction-to-abortion interval both significantly increased with gestation (p<.001), while analgesia requirements did not vary with increasing gestation (p=.18).
CONCLUSIONS: Medical abortion at 9-13 weeks' gestation is an effective alternative to surgery. Medical methods should be offered routinely at these gestations, thus increasing women's choice.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15854631     DOI: 10.1016/j.contraception.2004.10.015

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  5 in total

1.  Trends in use of medical abortion in the United States: reanalysis of surveillance data from the Centers for Disease Control and Prevention, 2001-2008.

Authors:  Karen Pazol; Andreea A Creanga; Suzanne B Zane
Journal:  Contraception       Date:  2012-07-06       Impact factor: 3.375

Review 2.  Pain management for medical abortion before 14 weeks' gestation.

Authors:  John J Reynolds-Wright; Mulat A Woldetsadik; Chelsea Morroni; Sharon Cameron
Journal:  Cochrane Database Syst Rev       Date:  2022-05-13

3.  The potential of medical abortion to reduce maternal mortality in Africa: what benefits for Tanzania and Ethiopia?

Authors:  Rebecca F Baggaley; Joanna Burgin; Oona M R Campbell
Journal:  PLoS One       Date:  2010-10-11       Impact factor: 3.240

4.  Implementing medical abortion with mifepristone and misoprostol in Norway 1998-2013.

Authors:  Mette Løkeland; Tone Bjørge; Ole-Erik Iversen; Rupali Akerkar; Line Bjørge
Journal:  Int J Epidemiol       Date:  2017-04-01       Impact factor: 7.196

5.  Presence of children in the home and intimate partner violence among women seeking elective pregnancy termination.

Authors:  Corinne Peek-Asa; Audrey F Saftlas; Anne B Wallis; Karisa Harland; Penny Dickey
Journal:  PLoS One       Date:  2017-10-12       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.